Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × All Solid Tumors × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 6 Neoplasms 3 Neoplasm Metastasis 3 Recurrence 2 Melanoma 2 Lymphoma, B-Cell, Marginal Zone 2 Head and Neck Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Nephrotic Syndrome 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced Bladder Cancer 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Diseases 1 Hepatitis B 1 Gastrointestinal Diseases 1 Familial Mediterranean Fever 1 Esophageal Neoplasms 1 Depression 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1 Anxiety Disorders 1 Amyloidosis 1

Interventions

Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡